Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Normal Prion Protein Maintains Myelin Integrity in Nervous System

By LabMedica International staff writers
Posted on 17 Aug 2016
Researchers studying chronic diseases of the brain have determined the function and mode of operation of the cellular prion protein PrPC, which in its cytotoxic form underlies prion diseases such as spongiform encephalopathy (mad cow disease) and its human counterpart, variant Creutzfeldt-Jakob disease.

Previous studies conducted by investigators at the University of Zurich (Switzerland) demonstrated that mice lacking PrPC had disruptions in the myeloid sheath, the insulating material derived from Schwann cells that surrounds nervous system axons, but the reasons for the disruptions were unclear.

In the current study, the University of Zurich researchers collaborated with investigators from the Washington University School of Medicine (St. More...
Louis, MO, USA) to determine the role and mode of action of normal PrPC.

The investigators reported in the August 8, 2016, online edition of the journal Nature that the cAMP concentration in sciatic nerves from PrPC-deficient mice was reduced, suggesting that PrPC acted via a G protein-coupled receptor (GPCR).

Working with mouse and zebrafish models, the investigators showed that PrPC attached to a GPCR on Schwann cells called Gpr126. The amino-terminal flexible tail (residues 23–120) of PrPC triggered a concentration-dependent increase in cAMP in primary Schwann cells, in the Schwann cell line SW10, and in HEK293T cells that over expressed Gpr126. By contrast, naive HEK293T cells and HEK293T cells expressing different GPCRs did not react to the flexible tail, and removal of Gpr126 from SW10 cells abolished the flexible tail-induced cAMP response.

“Previous studies have suggested a role for prion proteins in maintaining neurons, but until now, no one knew how the properly folded versions of the proteins function,” said contributing author Dr. Kelly R. Monk, associate professor of developmental biology at Washington University School of Medicine. “It is surprising to see that the protein has a role in maintaining the structure of nerve cells, considering that a misfolded version of PrPC is known to cause fatal brain diseases.”

“We have identified a definitive function for the normal prion protein and clarified how it works on a molecular level,” said senior author Dr. Adriano Aguzzi, professor of neuropathology at the University of Zurich. “Our study answers a question that has been intensely researched since the prion gene’s discovery in 1985.”

Related Links:
University of Zurich
Washington University School of Medicine

Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
CBM Analyzer
Complete Blood Morphology (CBM) Analyzer
Hemodynamic System Monitor
OptoMonitor
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.